Stock Events

Stock Events

Jasper Therapeutics (JSPR) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.61

-1.12

-0.64

-0.15

Details

Expected EPS

-1.088578

Actual EPS

-0.97

Surprise EPS

0.12

Surprise Percent

+10.89%

Description

Jasper Therapeutics (JSPR) has reported earnings of -0.97 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.